Thousand Oaks runs on a rare kind of asset: a clinical-trial dataset that can decide the value of a whole company, moving across hundreds of external partners who each hold a piece of it. CyberFortify runs manual API, web, cloud and network penetration tests here, aligned to 21 CFR Part 11 record integrity, GDPR international-transfer rules, HIPAA and SOC 2. Delivered remotely from our Gulf base on a daily overlap window, with on-site work where it genuinely helps. Fixed price, audit-ready reporting, free retest.
// 01 Why Thousand Oaks businesses need penetration testing
A biopharmaceutical company is not one network. It is a sponsor at the centre of a web of external partners - contract research organisations running the trials, sites collecting patient data across several countries, labs analysing samples, and cloud platforms managing the studies. The crown jewels, a molecule's IP and the clinical-trial data that proves whether it works, flow across every one of those boundaries.
That is what makes Thousand Oaks different. The dominant threat here is not commodity malware sweeping a flat office network. It is targeted: espionage aimed at a specific programme, an insider exfiltrating molecule IP, or an intrusion that reaches in through an over-trusted CRO or SaaS vendor and inherits access nobody re-checked. When a single dataset can be worth billions, a patient attacker spends months getting to it, and the weakest link is rarely the sponsor's own perimeter - it is the hundredth partner connected to it.
Scanning does not find that class of risk. A scanner reports an unpatched host; it cannot tell you that a CTMS login scoped to one study can read another study's subject data, that a CRO's service account still holds access to a programme it left last quarter, or that bulk export from an EDC platform reaches beyond the records that role should see. Those are authorisation and trust decisions, and confirming them takes a tester who understands both the protocol and the partner relationship behind it.
// 02 Compliance and regulatory drivers in Thousand Oaks
Biopharma answers to record-integrity rules for its trial data, privacy regimes on both sides of the Atlantic wherever studies run, and a partner-assurance bar before any CRO or vendor is trusted. These are the requirements we most often map evidence against.
21 CFR Part 11 - electronic record integrity
Part 11 governs the trustworthiness of electronic trial records and signatures. We probe whether audit trails can be tampered with or bypassed and whether access controls around trial data hold - the integrity questions Part 11 exists to answer.
GDPR & cross-border transfers
Trials run across Europe and beyond, so subject data crosses borders under GDPR and international-transfer rules. We test the interfaces and export paths that move that data between sponsor, CRO and sites for over-exposure and weak controls.
HIPAA / HITECH
Where US patient information is involved - in trials, real-world data or provider partnerships - the HIPAA Security Rule requires risk analysis and technical evaluation, and HITECH sets breach-notification duties.
SOC 2 & vendor assurance
CROs, labs and trial-platform vendors are assessed before contract and monitored after. SOC 2 reports and third-party risk programmes both rest on independent penetration-testing evidence - what a sponsor demands and a vendor must supply.
NIST CSF & ISO 27001
Large biopharma anchors its programme to NIST CSF and its enterprise vendors to ISO 27001 A.8.29 - both frame testing as evidence for identify, protect and detect across a complex partner estate.
CCPA/CPRA & PCI DSS 4.0
California's CCPA/CPRA adds consumer-privacy and risk-assessment duties over non-clinical data, and finance-sector partners handling card payments must penetration-test the cardholder environment under PCI DSS 4.0 Requirement 11.4.
// 03 Penetration testing services for Thousand Oaks
Thousand Oaks engagements weight trust boundaries and data flows over perimeters, because that is where a molecule's value is exposed. API and application testing lead for the trial platforms; cloud and identity follow, since the studies live there; network and red teaming cover intrusion and insider paths.
API pen testing
CTMS, EDC, trial-portal and integration APIs - broken object-level authorisation (BOLA/IDOR), scope enforcement, token handling and cross-study data exposure.
Cloud pen testing
Identity, tenant isolation, storage exposure and service-account scope across the clouds hosting trial data, analytics and the connections into CRO and vendor tenants.
Web application pen testing
Trial portals, investigator and sponsor dashboards and research applications, tested against the OWASP Top 10 and study-level business-logic abuse.
Network pen testing
External, internal and Active Directory testing - Kerberoasting, ADCS abuse and segmentation checks between research, corporate and partner-connection environments.
Mobile app pen testing
eConsent, ePRO and investigator apps - local data storage, certificate handling and the API traffic carrying subject data behind the screen.
Red teaming
Goal-based adversary simulation and insider-exfiltration scenarios, testing whether targeted intrusion or IP theft is detected before a programme's data leaves.
// 04 How we deliver to Thousand Oaks
We will not pretend otherwise: CyberFortify is a Gulf-based firm on UTC+3, and Thousand Oaks sits ten to eleven hours behind us. We have no California office and no local staff. What we have is a pattern built around that gap: our late afternoon and evening is your morning, and we hold that window open daily for stand-ups, live triage and read-outs. Testing continues while Thousand Oaks is offline, so results are waiting when your day starts.
What runs remotely
API, web, cloud, mobile and external testing from our secure environment - the large majority of clinical-platform, vendor-connection and IP-exposure scope. Findings land in a shared channel as confirmed, and critical issues are escalated at once.
What we do on-site
Internal network, wireless and segmentation testing where a tester needs to be on the wire, plus in-person workshops for security and clinical-operations committees. We travel when it adds value and say so when it does not.
Every engagement opens with a free 30-minute scoping call and a fixed-price quote within the hour. For live-trial and validated environments we agree test windows and controlled data around study operations, and a free retest proves the fixes.
// 05 Industries we secure in Thousand Oaks
Thousand Oaks's risk profile is shaped by a dense biopharma cluster and the ecosystem of research, lab, healthcare and financial-services partners around it.
// 06 Our methodology
Thousand Oaks engagements follow the same audit-defensible process we run everywhere, tuned to the trial data and partner web at the centre of this market. Testing is grounded in the PTES and NIST SP 800-115, with exploitation mapped to MITRE ATT&CK and application work driven by OWASP, including the API Security Top 10. As a CREST Accreditation Pathway firm we lead with manual testing - automation supports the tester, never replaces one.
Scoping & rules of engagement
Targets, trial platforms, CRO and vendor connection boundaries, test accounts and escalation paths agreed in writing first.
Fixed quote in 1hReconnaissance & threat modelling
Attack surface mapped around the data itself - who holds which study, which partner connects with what token, and where molecule IP could leak or be exfiltrated.
ATT&CK alignedManual exploitation
Weaknesses are exploited and chained under controlled conditions, with cross-study and insider access proven using seeded test records - never live subject or patient data.
Controlled exploitReporting & free retest
Executive summary, CVSS-scored detail and mapping to 21 CFR Part 11, GDPR, HIPAA, SOC 2 or NIST CSF - plus a free retest once fixes ship.
Audit-ready// 07 Why CyberFortify for Thousand Oaks
A scan-and-report vendor
Automated output rebadged as a penetration test, blind to authorisation logic and trust boundaries, unable to reason about who a token belongs to or what an over-trusted CRO account reaches.
CyberFortify
A Gulf-based, CREST-pathway team candid about the time difference and structured around it. Manual exploitation aimed at clinical-trial data, the CRO and vendor supply chain and insider paths, findings mapped to your auditors' and partners' frameworks, fixed pricing and a free retest.
Thousand Oaks engagements most often pair an API assessment of the trial platforms with a cloud penetration test, since a study's risk splits between the authorisation logic in front of the data and the identity and vendor connections underneath. Where espionage or IP theft is the concern, we add red teaming to test whether targeted intrusion and insider exfiltration are caught in time.
// 08 Frequently asked questions
How do you test a CRO or trial-site connection into our biopharma environment?
We treat every partner connection as an untrusted entry point rather than a trusted extension of your network. We test how a contract research organisation, trial site or lab authenticates into your systems, whether the service accounts and API keys behind those links are over-scoped, and whether an identifier in a request can be changed to reach a different study or sponsor. We test from the positions a real attacker would take, including a compromised CRO account and a hostile trial-site partner, and we map how far that access reaches before anything stops it.
Can you test our CTMS and EDC platforms for cross-study and cross-subject access?
Yes - clinical-trial management and electronic data capture platforms are a core target here. We test the authorisation model behind the trial portal: whether a login scoped to one study can read another study's data, whether subject and record identifiers can be enumerated or substituted through IDOR and BOLA flaws, whether roles are enforced per request rather than only at the menu, and whether bulk export or reporting reaches beyond the assigned scope. Where 21 CFR Part 11 applies, we also probe whether audit trails and record integrity can be tampered with or bypassed.
Which regulations and standards drive penetration testing for Thousand Oaks biopharma?
The value and sensitivity of clinical-trial data is the anchor. 21 CFR Part 11 governs the integrity and audit-trail controls around electronic trial records. Where trials run outside the US, GDPR and international data-transfer rules apply to subject data crossing borders, and HIPAA applies where US patient information is involved. Vendors and CROs are assessed against SOC 2 and formal third-party risk-management expectations before contract, and many sponsors anchor the wider programme to NIST CSF. We map each finding to the frameworks your auditors and partners actually use.
With your team in the Gulf, how does the time gap work for a Thousand Oaks engagement?
We should be plain: CyberFortify is a Gulf-based firm on UTC+3, ten to eleven hours ahead of Thousand Oaks, with no California office or local staff. We hold a deliberate daily overlap window - our late afternoon and evening is your morning - reserved for stand-ups, live triage and read-outs with your security and clinical teams. Testing continues while your team is offline, so confirmed findings are usually waiting when the California day begins.
How fast can we get a quote for a Thousand Oaks engagement?
Book a free 30-minute scoping call and we return a fixed-price quote, usually within the hour and always within one business day. The report is written to hand straight to an auditor or a partner's security review, and a remediation retest is included once your fixes ship.